在儿科急性淋巴细胞白血病中选择的干细胞种群
Anna Krętowska-Grunwald1,2, Małgorzata Sawicka-Żukowska2, Aleksandra Starosz1
1Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.
Frontiers in immunology
|October 10, 2024
概括
造血干细胞 (HSC) 和非常小的胚胎样干细胞 (VSEL) 在儿科急性淋巴细胞白血病 (ALL) 中发生变化. 这些干细胞的变化与疾病进展和治疗反应相关,具有预后价值.
科学领域:
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
- 儿科瘤学 儿科瘤学
背景情况:
- 急性淋巴细胞白血病 (ALL) 涉及异常的造血干细胞 (HSC) 成熟,导致恶性克隆.
- 在ALL中疾病复发可能源于不完整的根除或克隆进化.
- 干细胞,特别是非常小的胚胎样干细胞 (VSELs) 和高细胞干细胞在ALL病原和治疗反应中的作用需要进一步阐明.
研究的目的:
- 调查儿童ALL治疗诱导阶段VSEL和HSC的动态变化.
- 确定VSEL和HSC水平与ALL诊断,疾病进展和治疗结果之间的相关性.
主要方法:
- 一项回顾性研究分析了来自60名儿科ALL患者和48名健康对照者的外周血液和骨髓样本.
- 流细胞计被用来评估VSEL和HSC群体在四个不同的时间点.
- 分析了数据,以将干细胞水平与临床参数相关联,包括骨髓爆发和最小残留疾病 (MRD).
主要成果:
- 与对照组相比,VSEL和HSC都在ALL诊断时升高,到第15天显著下降.
- 从第15天到第12周,HSC增加,而VSEL减少.
- 较高的初始HSC与增加的骨髓爆发相关;诊断时较低的VSEL或HSC表明治疗反应有所改善. 诊断时较低的VSEL预测了15日MRD水平的较低水平.
结论:
- HSC和VSEL在儿科ALL中起着重要作用,可能有助于瘤过程.
- 这些干细胞群体在预测儿科ALL初始治疗结果方面具有预后价值.
- 监测VSEL和HSC动态可能有助于对ALL的风险分层和个性化治疗策略.
更多相关视频
相关概念视频
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:22Bone Marrow Sampling and Transplants
312
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
312
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:34Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K